Dr. Brian Bannister is First in New Jersey to Offer New Treatment Option for Chronic Pain
Plano, Texas (PRWEB) August 29, 2017 -- Brian Banister, MD is the first pain medicine physician in New Jersey to implant Nuvectra’s Algovita® Spinal Cord Stimulation System, a powerful and versatile spinal cord stimulation system that also offers the smallest patient control device. The Nuvectra™ Algovita SCS System has been FDA approved as a treatment option for chronic intractable pain.
“The beauty of the Algovita system is that I believe it is the only system that provides all the different stimulation options to treat my patients’ pain,” Dr. Bannister explains. “A lot of patients in my practice like to feel their stimulation during periods of increased pain.”
Dr. Bannister also notes, “With the standard-spaced, 12-contact leads in the Algovita system, I’m able to span a larger length of the spinal cord to achieve better coverage of back and leg pain that was hard to capture before.”
Chronic pain affects over 100 million Americans according to the Institute of Medicine, more than diabetes, cancer, and heart disease combined. Chronic pain is difficult to treat, but one potential treatment option is spinal cord stimulation, or SCS. SCS works by masking or interrupting pain signals as they travel up the spinal cord to the brain. A small, rechargeable battery is implanted under the patient’s skin and connected to thin wires, called leads, which stimulate the nerves sending pain signals. The stimulation “overrides” the pain signals, and instead of feeling pain, patients may feel a tingling sensation known as paresthesia.
The Algovita SCS System is a new offering to the SCS market, featuring 24 current sources and the broadest overall set of parametric ranges offered for tonic SCS. This combination provides flexible coverage and expanded programming options for individualized patient therapy. Algovita also offers the industry’s only stretchable leads, which are designed to reduce the risk of lead fracture and migration. In addition, the system’s percutaneous leads feature up to 12 contacts for wide coverage of potential pain areas. The Algovita system was designed to be patient-centric and easy to use. The wireless Pocket Programmer fits discreetly in a hand, purse, or pocket and allows a patient to conveniently adjust their therapy on the go.
For more information about Nuvectra and the Algovita Spinal Cord Stimulation system, visit http://www.nuvectramed.com.
About Dr. Bannister
Dr. Brian Bannister is a pain medicine doctor for Progressive Pain Management in Monmouth County, New Jersey. He offers a multimodal approach to pain control. This ranges from physical therapy and medication management to minimally invasive spine surgery. Dr. Bannister is affiliated with Monmouth Medical Center- Southern Campus, Monmouth Medical Center, and Saint Barnabas Medical Center.
About Nuvectra Corporation
Nuvectra is a neurostimulation company committed to helping physicians improve the lives of people with chronic neurological conditions. The Algovita Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other neurological indications such as sacral neuromodulation (SNM) for the treatment of overactive bladder and deep brain stimulation (DBS) for the treatment of Parkinson's Disease. In addition, our NeuroNexus subsidiary designs, manufactures, and markets leading-edge neural-interface technologies for the neuroscience clinical research market. Visit the Nuvectra website at http://www.nuvectramed.com.
Jennifer Armstrong, Nuvectra Corporation, http://www.nuvectramed.com, +1 (214) 474-3110, [email protected]
Share this article